Related Experiment Video
Updated: Feb 4, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Pharmacotherapy of Down syndrome
Michelle L Palumbo1, Christopher J McDougle2
1a Instructor in Pediatrics, Harvard Medical School , Lurie Center for Autism , Lexington , MA , USA.
Psychiatric conditions are common in Down syndrome (DS), but treatment options are limited. This review outlines expert-recommended pharmacotherapy for conditions like depression, anxiety, and ADHD in individuals with DS.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Comorbid psychiatric disorders frequently occur in individuals with Down syndrome (DS).
- Limited evidence exists for the pharmacotherapy of psychiatric conditions in DS.
- This review addresses the pharmacotherapy of common co-occurring psychiatric conditions in DS.
More Related Videos
08:31Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
Published on: July 31, 2016
09:39Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
Published on: December 4, 2021
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...